Shields John L. sold $28K of EVER

Shields John L. sold 1,366 shares of EverQuote, Inc. (EVER) at $20.83 on 2026-10-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shields John L.
Published Oct 13, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Neutral
high confidence
Mentioned
$EVER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to shift EverQuote's share price, but it provides transparency for investors monitoring insider behavior.

02

Market read

A routine insider sale with limited market impact; useful for compliance monitoring but low trading relevance.

03

What to watch

Potential upcoming earnings or product announcements could amplify the impact of any insider activity.

Relevance 2/10Novelty 2/10Timing: post‑market filing on Oct 13

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$EVERNeutralHigh confidence
Context

Director John L. Shields sold 1,366 EVER shares for $28,453.78 on Oct 9 via a 10b5‑1 plan.

Expected impact

likely minimal pressure as the market prices in the modest sell amount

Evidence & confidence

The transaction size ($28K) is trivial relative to EverQuote's market cap; directors' 10b5‑1 sales are routine and rarely move the stock.

Market effects

None; the sale does not affect the broader insurance‑tech sector.

None; limited to EverQuote investors.

None

Counterpoint

If the director anticipates near‑term weakness, the sale could foreshadow a short‑term dip.

Key entities

  • EverQuote, Inc.

    US‑listed insurance‑tech firm (NASDAQ: EVER).

  • John L. Shields

    Director of EverQuote who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.